» Articles » PMID: 19643181

The Physiological and Pathophysiological Role of PRMT1-mediated Protein Arginine Methylation

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2009 Aug 1
PMID 19643181
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Post-translational modifications are well-known effectors in DNA damage signaling and epigenetic gene expression. Protein arginine methylation is a covalent modification that results in the addition of methyl groups to the nitrogen atoms of the arginine side chains and is catalyzed by a family of protein arginine methyltransferases (PRMTs). In the past, arginine methylation was mainly observed on abundant proteins such as RNA-binding proteins and histones, but recent advances have revealed a plethora of arginine-methylated proteins implicated in a variety of cellular processes including signal transduction, epigenetic regulation and DNA repair pathways. Herein, we discuss these recent advances, focusing on the role of PRMT1, the major asymmetric arginine methyltransferase, in cellular processes and its link to human diseases.

Citing Articles

Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy.

Huang D, Rezaeian A, Wang J, Qi Y, Chen H, Inuzuka H J Cancer Biol. 2025; 5(2):44-60.

PMID: 40018367 PMC: 11867627. DOI: 10.46439/cancerbiology.5.064.


Biomedical effects of protein arginine methyltransferase inhibitors.

Cao M, Nguyen T, Song J, Zheng Y J Biol Chem. 2025; 301(3):108201.

PMID: 39826691 PMC: 11871472. DOI: 10.1016/j.jbc.2025.108201.


PRMT1-mediated methylation regulates MLL2 stability and gene expression.

An D, Kim J, Moon B, Kim H, Nguyen H, Park S Nucleic Acids Res. 2024; 53(4).

PMID: 39698834 PMC: 11879031. DOI: 10.1093/nar/gkae1227.


Targeting pivotal amino acids metabolism for treatment of leukemia.

Hong J, Liu W, Xiao X, Gajendran B, Ben-David Y Heliyon. 2024; 10(23):e40492.

PMID: 39654725 PMC: 11626780. DOI: 10.1016/j.heliyon.2024.e40492.


Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.

Zhang Y, Xu W, Peng C, Ren S, Zhang C J Transl Med. 2024; 22(1):651.

PMID: 38997696 PMC: 11245821. DOI: 10.1186/s12967-024-05455-6.